Fuji Pharma Co., Ltd. (TSE: 4554)
Health Care · Pharmaceuticals · JP
¥1,780.00
+3.49% today · +12.6% 1Y
Fuji Pharma Co., Ltd. (TSE: 4554) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $293.63M and employs 1,760 people.
Over the last twelve months the share price has gained 12.6%, trading between 1.53K and 2.56K.
Tweenvest scores Fuji Pharma Co., Ltd. across four factors: quality 71/100, value 67/100, growth 47/100, dividend 78/100. Its strongest factor is dividend.
4554 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $293.63M
- Revenue (TTM)
- $369.77M
- P/E
- 14.91
- EPS
- 119.39
- Dividend yield
- 2.75%
- Beta (5Y)
- 0.33
- 52-week high
- ¥2,559.00
- 52-week low
- ¥1,535.00
- Avg volume (3M)
- —
- Shares outstanding
- 26.12M
- Employees
- 1,760
- Next earnings
- —
About Fuji Pharma Co., Ltd.
Fuji Pharma Co., Ltd. is a pharmaceutical company that operates globally, focusing on the complete spectrum of drug development, from initial research and discovery through manufacturing and commercialization. Its comprehensive product line includes various medical solutions such as injectable medications, oral therapeutics, topical treatments, and a range of diagnostic tools. Beyond its core pharmaceutical offerings, Fuji Pharma also specializes in women's healthcare products, advanced in vitro diagnostic technologies, and acute medical intervention solutions. The company further contributes by disseminating valuable pharmaceutical and general health information. Founded in 1965, Fuji Pharma Co., Ltd. has its corporate headquarters located in Tokyo, Japan.
- ISIN
- JP3816200004
- Founded
- 1965
- Listed since
- Feb 22, 2010
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhejiang Benli Technology Co., Ltd.SZSE: 301065 | $297.77M | CN¥19.88 | -0.90% |
| Bukwang Pharmaceutical Co., Ltd.KOSE: A003000 | $297.60M | ₩4,055.00 | -1.10% |
| Shanghai Hile Bio-Technology Co., Ltd.SHSE: 603718 | $296.48M | CN¥3.06 | -0.97% |
| Aurora Cannabis Inc.TSX: ACB | $295.82M | CA$6.42 | +1.58% |
| EyePoint, Inc.NasdaqGM: EYPT | $293.12M | $3.40 | +4.62% |
| BioAge Labs, Inc.NasdaqGS: BIOA | $290.99M | $6.34 | +2.09% |
| Lavipharm S.A.ATSE: LAVI | $288.74M | €1.51 | -3.70% |
| Fulcrum Therapeutics, Inc.NasdaqGM: FULC | $287.64M | $3.77 | +0.53% |
Figures last refreshed Oct 11, 2026.